A comment was published on 17 December 2010, see Pharmaceuticals 2010, 3(12), 3629-3632.

Pharmaceuticals 2010, 3(6), 1909-1935; doi:10.3390/ph3061909

Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications

Received: 26 April 2010; in revised form: 11 May 2010 / Accepted: 9 June 2010 / Published: 11 June 2010
(This article belongs to the Special Issue Antiepileptic Drugs)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: In the past twenty years, 14 new antiepileptic drugs have been approved for use in the United States and/or Europe. These drugs are eslicarbazepine acetate, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, pregabalin, rufinamide, stiripentol, tiagabine, topiramate, vigabatrin and zonisamide. In general, the clinical utility of therapeutic drug monitoring has not been established in clinical trials for these new anticonvulsants, and clear guidelines for drug monitoring have yet to be defined. The antiepileptic drugs with the strongest justifications for drug monitoring are lamotrigine, oxcarbazepine, stiripentol, and zonisamide. Stiripentol and tiagabine are strongly protein bound and are candidates for free drug monitoring. Therapeutic drug monitoring has lower utility for gabapentin, pregabalin, and vigabatrin. Measurement of salivary drug concentrations has potential utility for therapeutic drug monitoring of lamotrigine, levetiracetam, and topiramate. Therapeutic drug monitoring of the new antiepileptic drugs will be discussed in managing patients with epilepsy.
Keywords: anticonvulsants; drug monitoring; drug toxicity; epilepsy; seizures
PDF Full-text Download PDF Full-Text [293 KB, uploaded 14 June 2010 11:19 CEST]

Export to BibTeX |

MDPI and ACS Style

Krasowski, M.D. Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications. Pharmaceuticals 2010, 3, 1909-1935.

AMA Style

Krasowski MD. Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications. Pharmaceuticals. 2010; 3(6):1909-1935.

Chicago/Turabian Style

Krasowski, Matthew D. 2010. "Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications." Pharmaceuticals 3, no. 6: 1909-1935.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert